Filtered By:
Condition: Obesity
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3042 results found since Jan 2013.
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.ABSTRACTThe severity of the 2019 coronavirus disease (COVID-19) and its effects remain unpredictable. Certain factors, such as obesity, hypertension, and type 2 diabetes mellitus, may increase the severity of the disease. Rheumatology experts suggest that patients with active autoimmune conditions and controlled autoimmune diseases on immunosuppressive therapy may be at higher risk of developing severe COVID-19. In this retrospective observational study, we aimed to examine the patterns of COVID-19 in patients with underlying rheumatological diseases and their...
Source: Journal of Medicine and Life - September 7, 2023 Category: General Medicine Authors: Safi Alqatari Ameera Nemer Manal Hasan Raed Bukhari Reem Al Argan Dania Al Khafaji Abrar Alwaheed Alaa Alzaki Marwan Al-Wazza Sara Al Warthan Abir Al Saeed Feda Albeladi Hashim Almeer Reem AlSulaiman Ahmed Abu Quren Source Type: research
Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome
CONCLUSIONS: COVID-19 was associated with long-term depression risk in older adults with overweight/obesity and metabolic syndrome, particularly in women. Thus, long-term evaluations of the impact of COVID-19 on mental health and preventive public health initiatives are warranted in older adults.PMID:37667630 | DOI:10.1017/S0033291723002313
Source: Psychological Medicine - September 5, 2023 Category: Psychiatry Authors: Sangeetha Shyam Carlos G ómez-Martínez Indira Paz-Graniel Jos é J Gaforio Miguel Ángel Martínez-González Dolores Corella Montserrat Fit ó J Alfredo Mart ínez Ángel M Alonso-Gómez Julia W ärnberg Jes ús Vioque Dora Romaguera Jos é López-Miran Source Type: research
Perindopril and losartan attenuate pro-coagulation factors in human adipocytes exposed to SARS-CoV-2 spike protein
This study use adipose tissue harvested from an obese male donor was isolated and exposed to perindopril, losartan, and ACE2 recombinant as binding assay, following exposure with 10 nm of SARS-CoV-2 S1 spike protein. After 48 hours, tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) as pro-coagulation factors as well as ACE2 levels and binding evaluated. The results shows TF level was significantly reduced in Perindopril group compared to control (4.834; p=0.005), while a non-significant reduction was observed in Losartan group (5.624; p=0.111). However, Losartan group showed a better reduction of PAI-1 level...
Source: J Physiol Pharmacol - September 3, 2023 Category: Drugs & Pharmacology Authors: M Ardiana I G R Suryawan H O Hermawan P M Harsoyo I M Sufiyah A R Muhammad B S I Zaini Source Type: research
